Edition:
United States

Orion Oyj (ORNBV.HE)

ORNBV.HE on Helsinki Stock Exchange

40.71EUR
11:29am EDT
Change (% chg)

€-0.69 (-1.67%)
Prev Close
€41.40
Open
€41.20
Day's High
€41.50
Day's Low
€40.71
Volume
482,623
Avg. Vol
306,511
52-wk High
€58.50
52-wk Low
€33.59

Latest Key Developments (Source: Significant Developments)

Orion Q2 EBIT EUR 71.8 mln, below estimates
Wednesday, 19 Jul 2017 06:16am EDT 

July 19 (Reuters) - ORION OYJ ::OUTLOOK ESTIMATE FOR 2017 REMAINS UNCHANGED.ESTIMATES THAT IN 2017 NET SALES WILL BE AT SIMILAR LEVEL TO 2016.Q2 NET SALES EUR ‍272.4​ MILLION (REUTERS POLL EUR 277 MILLION).SEES 2017 OPERATING PROFIT EXCLUDING MATERIAL CAPITAL GAINS WILL BE AT LEAST EUR 280 MILLION.Q2 EBIT EUR 71.8 MILLION (REUTERS POLL EUR 83.0 MILLION).SHARES DOWN 3.4 PERCENT AFTER CO PUBLISHES Q2 RESULTS.  Full Article

Orion co-operation negotiations in Oulu completed
Friday, 2 Jun 2017 04:06am EDT 

June 2 (Reuters) - ORION OYJ ::ORION DIAGNOSTICA'S CO-OPERATION NEGOTIATIONS IN OULU COMPLETED.‍NEGOTIATIONS CONCERNED 14 EMPLOYEES, WHO WILL PRIMARILY BE OFFERED A TRANSFER TO ORION DIAGNOSTICA'S LOCATION IN ESPOO.​.DECISION HAS BEEN MADE TO TERMINATE OPERATIONS OF ORION DIAGNOSTICA OY IN OULU AND MOVE OPERATIONS ENTIRELY TO ESPOO.‍OPERATIONS OF ORION DIAGNOSTICA OY IN CURRENT PREMISES WILL END BY END OF SEPTEMBER 2017 AT LATEST​.  Full Article

Orion Q1 sales up at EUR 279.2 million, above expectations
Wednesday, 26 Apr 2017 05:00am EDT 

April 26 (Reuters) - ORION OYJ : :Q1 SALES EUR 279.2 MILLION (REUTERS POLL EUR 269 MILLION).OUTLOOK ESTIMATE FOR 2017 REMAINS UNCHANGED.HIGHER OPERATING PROFIT WAS DUE TO GROWTH IN NET SALES.Q1 EBIT EUR 91.7 MILLION (REUTERS POLL EUR 80.8 MILLION).  Full Article

Orion Diagnostica initiates co-operation negotiations in Oulu
Thursday, 6 Apr 2017 07:00am EDT 

ORION OYJ : ORION DIAGNOSTICA INITIATES CO-OPERATION NEGOTIATIONS CONCERNING 14 PERSONS IN OULU . ORION DIAGNOSTICA INITIATES CO-OPERATION NEGOTIATIONS CONCERNING 14 PERSONS IN OULU . OPERATIONS OF ORION DIAGNOSTICA OY IN CURRENT PREMISES WILL END BY END OF SEPTEMBER 2017 AT LATEST. . NEGOTIATIONS CONCERN 14 EMPLOYEES. .SHOULD REDUNDANCIES OCCUR, EMPLOYER WOULD, ACCORDING TO A PRELIMINARY ESTIMATE, GIVE NOTICES DURING 2017..  Full Article

Orion Oyj Q4 EBIT at EUR 58.7 million, above estimates
Wednesday, 8 Feb 2017 05:01am EST 

Orion Oyj : Q4 sales 279.9 million euros ($298.18 million) versus 273 million euros seen in Reuters poll . Q4 EBIT 58.7 million euros (Reuters poll 56.5 million) . Proposes dividend of 1.35 euro per share and 0.20 euro special dividend per share, in total 1.55 euro per share (Reuters poll: 1.45 euro per share) . Says net sales of business division turned to growth in 2016 for first time since start of generic competition for Parkinson's franchise . CEO says "Clear growth in operating profit is explained by growth in net sales and about 22 million euros of total capital gains" .Sees 2017 net sales at similar level to 2016 and operating profit ex. material capital gains to be at least 280 million euros.  Full Article

Orion to divest food business into new subsidiary for system transformation
Tuesday, 22 Nov 2016 04:42am EST 

Orion Corp <001800.KS> : Says it will divest its food business into a new subsidiary, named Orion Corp . Says it will change company name to Orion Holdings Corp and will be engaged in subsidiary management and investment, for holding company system transformation .Divesture effective date is June 1, 2017 and expected registered date is June 5, 2017.  Full Article

Orion Oyj and Menarini Group enter into collaboration agreement
Friday, 2 Sep 2016 06:10am EDT 

Orion Oyj : Says the company and Menarini Group collaborate on budesonide-formoterol Easyhaler combination product for asthma and COPD . Agreement is for co-marketing of Easyhaler in Germany, Italy, Spain, and Portugal . Parties have also agreed on exclusive license and distribution arrangement in France and Turkey . Parties will market budesonide-formoterol Easyhaler under their own brands .Menarini Group is Italian pharmaceutical company.  Full Article

Orion Q2 EBIT beats expectations at EUR 83.5 million
Tuesday, 19 Jul 2016 05:00am EDT 

Orion Oyj : Q2 EBIT 83.5 million euros ($92.4 million) (Reuters poll 74.4 million euros) . Q2 sales 273.1 million euros (Reuters poll 266 million euros) . Estimates that in 2016 net sales will be slightly higher than in 2015 .2016 operating profit excluding possible capital gains is estimated to exceed 270 million euros.  Full Article

Orion Corporation and Asahi Kasei enters into global strategic collaboration
Wednesday, 22 Jun 2016 01:00am EDT 

Orion Oyj : Says that it has entered into a global strategi collaboration agreement with Japanese Asahi Kasei Pharma for the discovery, development and commercialisation of assets in pain management . Agreement comprises a total of four discovery phase candidates, two from Asahi Kasei and two from Orion .Collaboration allows both companies to exclusively license others' development-ready programs at pre-determined stages.  Full Article

Orion completes share buyback
Thursday, 16 Jun 2016 03:37am EDT 

Orion Oyj : Said on Wednesday it completed share acquisitions . Bought total of 500,000 own B shares at average price of about 33.5319 euros per share . Total purchase price was 16,765,946.50 euros ($18.89 million) .It holds now total of 783,366 own B shares corresponding to about 0.55 pct of total number of shares and 0.09 pct of votes.  Full Article

BRIEF-Shareholders of Osisko Gold Royalties Ltd approve Orion transaction

* Osisko Gold Royalties Ltd - shareholders have approved at 99.6% issuance of shares required to complete acquisition of Orion portfolio